CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes 10-Year Outcomes of Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease Ticagrelor Monotherapy Versus Ticagrelor With Aspirin in Patients With ST-Segment Elevation Myocardial Infarction Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers When, where, and how to target vascular inflammation in the post-CANTOS era? Left Main Revascularization in 2017: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention? MINOCA: a heterogenous group of conditions associated with myocardial damage Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI Evolving concepts in the management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation Ticagrelor With or Without Aspirin in High-Risk Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention

Clinical Trial2021 Jul 19;ehab449.

JOURNAL:Eur Heart J. Article Link

Post-stenting fractional flow reserve vs coronary angiography for optimisation of percutaneous coronary intervention: TARGET-FFR trial

D Collison, M Didagelos, M Aetesam-Ur-Rahman et al. Keywords: coronary physiology; FFR; ischaemic heart disease; PCI optimization

Full Text PDF